Talk to sales Try for Free
Xueting Wang

Xueting Wang

IGEM 2017

Followers of Xueting Wang562 followers
location of Xueting WangGothenburg, Västra Götaland County, Sweden

Connect with Xueting Wang to Send Message

Connect

Connect with Xueting Wang to Send Message

Connect

  • Timeline

  • About me

    Senior Scientist at AstraZeneca | PhD in Immunology

  • Education

    • University of Helsinki

      2018 - 2018
      ERASMUS Internship Virology

    • The University of Freiburg

      2016 - 2019
      Master of Science - MS Biology, General

      Master Thesis: Cancer Immunotherapy- The Development of Second-generation T Cell Receptor Fusion Constructs- responsible for a pre-clinical project in collaboration with the company TCR2 Therapeutics- generation of second-generation T cell receptor fusion constructs (TRuCs)- transduction of human primary T cells, test for cytokine release, specific cytotoxicity, and T cell exhaustion in comparison with the two FDA approved Chimeric Antigen Receptors

    • The University of Freiburg

      2020 - 2023
      Doctor of Philosophy - PhD Immunology

      Project: Identification of Modulators for enhanced CAR T cell Function.

    • The University of Freiburg

      2013 - 2016
      Bachelor's degree Biology, General

  • Experience

    • BIOSS Centre for Biological Signalling Studies

      Jan 2017 - Nov 2017
      IGEM 2017

      As a member of Freiburg iGEM 2017, we worked on a project called "CARTEL" (Chimeric Antigen Receptor on T cells Expressed Locally in the tumor microenvironment)- responsible for all the cell culture experiments- generated stable human cell lines to test factors of the tumor microenvironment- created team's wiki

    • University of Helsinki

      Aug 2018 - Sept 2018
      Research Intern

      - virus screening- test for infection-models

    • Universität Freiburg

      Jan 2019 - Jun 2019
      Student Assistant

    • Miltenyi Biotec

      Mar 2020 - Aug 2023
      PHD Student

      Research on tumour escape mechanisms after CAR T cell treatment with the focus on the essential molecular interactions between CAR T cells and their targets.

    • AstraZeneca

      Oct 2023 - now
      Senior Scientist

      - R&D of CAR-TREG therapies for non-oncology indications.- Biomarker discovery and assay development.

  • Licenses & Certifications

    • FELASA function A

      The University of Freiburg
      Nov 2021

  • Honors & Awards

    • Awarded to Xueting Wang
      Gold Medal Winner International Genetically Engineered Machine (iGEM) Nov 2017